Literature DB >> 15742188

Cytogenetic analysis of 52 Indian patients with de novo myelodysplastic syndromes-a comparative analysis of results with reports from Asia.

Amirtha Ganesh Dakshinamurthy1, Nicolas Novitzky, Raghva Bharadwaj, Balakrishna Murthy Prakhya.   

Abstract

Most published data on myelodysplastic syndromes (MDS) are derived from Western countries, which report MDS as a disease of the elderly. However, it was observed that Asian MDS patients were younger than subjects in Western reports. With this in mind, the study was conducted prospectively on 52 Indian patients to define chromosomal abnormalities and to understand ethno-geographical differences, if any, underlying the pathogenesis of MDS among this Asian population. Cytogenetic analysis was performed using GTG banding and karyotyped according to the International System for Human Cytogenetic Nomenclature (ISCN). The incidence of MDS was predominant in the age group of 41-60 years (44.23%), with a median age at diagnosis of 55 years. The disease was more frequent in males (33 patients, 63.46%) than females (19 patients, 36.53%). Of 48 patients successfully karyotyped, 17 had normal karyotype (35.4%) and 31 patients (64.5%) had a chromosomal abnormality. The most frequent chromosome abnormalities were del 5q/-5 in 13 patients (42%), -7/7q- in 10 patients (32.2%), +8 and del 20q- in 6 cases each (19.3%) and i(17)(q10) in 1 patient (3.2%). In addition to these non-random chromosomal abnormalities, some rare abnormalities were also encountered. A higher rate of transformation to acute myeloid leukaemia (AML) was observed in the Chinese population compared to other Asian countries. The incidence of chromosomal abnormalities varied considerably across the different Asian populations. The overall frequency of chromosomal abnormalities in our study was comparable to most Western reports. Further prospective studies are warranted to elucidate precisely the ethnic differences in the pathogenesis of MDS in the Indian population.

Entities:  

Mesh:

Year:  2005        PMID: 15742188     DOI: 10.1007/s00277-004-0997-x

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  3 in total

1.  First Cytogenetic Profile of Omani Patients with de novo Myelodysplastic Syndromes: Comparison with data from Asia, Africa, Europe and North and South America.

Authors:  Achandira M Udayakumar; Nagla Fawaz; Anil Pathare; Shakila Asraf; Mohammed Al-Huneini; Khalil Al-Farsi; Salam Al-Kindi; Murtadha Al-Khabouri
Journal:  Sultan Qaboos Univ Med J       Date:  2017-10-10

2.  Clinico-Hematological and cytogenetic spectrum of adult myelodysplastic syndrome: The first retrospective cross-sectional study in Iranian patients.

Authors:  Mostafa Paridar; Kazem Zibara; Seyed Esmaeil Ahmadi; Abbas Khosravi; Maral Soleymani; Ebrahim Azizi; Omid Kiani Ghalesardi
Journal:  Mol Cytogenet       Date:  2021-05-08       Impact factor: 2.009

3.  Cytogenetic profile of Indian patients with de novo myelodysplastic syndromes.

Authors:  Rekha Chaubey; Sudha Sazawal; Rima Dada; Manoranjan Mahapatra; Renu Saxena
Journal:  Indian J Med Res       Date:  2011-10       Impact factor: 2.375

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.